Bendroflumethiazide
- Generic Name
- Bendroflumethiazide
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C15H14F3N3O4S2
- CAS Number
- 73-48-3
- Unique Ingredient Identifier
- 5Q52X6ICJI
- Background
A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
- Indication
For the treatment of high blood pressure and management of edema related to heart failure.
- Associated Conditions
- Hypertension
- Associated Therapies
- -
Mechanisms of Diuretic Resistance in Heart Failure, Aim 2
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Yale University
- Target Recruit Count
- 50
- Registration Number
- NCT05753059
- Locations
- 🇺🇸
Yale University, New Haven, Connecticut, United States
A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-09-10
- Last Posted Date
- 2014-09-10
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 26
- Registration Number
- NCT02235402
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath